Glooko
Diabetes: Glooko’s new population tracker highlights at-risk patients
California diabetes management company Glooko Inc. this month unveiled its new Population Tracker, offering health systems patient monitoring that aims to keep track of at-risk patients and reduce hospitalizations.
2013 year in review: Our 6 best interviews of the year
Can Glooko disrupt the way diabetes is managed?
Glooko continues to carve out a niche in the mobile diabetes management space.
Diabetes: Glooko taps the Android market with new FDA clearance
Silicon Valley mHealth company Glooko is expanding its FDA-approved mobile diabetes management system to include an app for the Android operating system.
Palo Alto, Calif.-based Glooko received 510(k) clearance from the FDA for the Android app and a new cable to connect to glucose monitors, a move company officials say will help it expand internationally.
Diabetes in the iPhone age: Q&A with Glooko CEO Rick Altinger
Silicon Valley mHealth company Glooko is rocketing forward in the mobile diabetes management space since its inception less than 3 years ago, boasting multiple FDA clearances, wide-ranging industry partnerships and a growing base of patient users and healthcare provider subscribers.
Just last month, Glooko won FDA clearance for the 2nd generation of its iPhone diabetes management app and launched the 1st subscriber portal at San Diego’s Scripps Whittier Diabetes Institute.
FDA clears new smartphone health monitoring technologies
A growing demand for mobile health monitoring devices led to a boom in mobile devices that allow patients to manage chronic illnesses and measure body metrics at home. Now, several companies have won FDA clearance for next-generation health monitoring devices that connect wirelessly to mobile apps and software.
Palo Alto, Calif.-based Glooko will begin selling its second glucose monitoring app and cable device. This product comes with enhanced software that allows patients to program health goals and enhanced data security through advanced encryption.
Diabetes: Glooko links up with Wal-Mart | Wall Street Beat
Diabetes: iPhones merge wirelessly with glucose meters | MassDevice.com On Call
MASSDEVICE ON CALL — Roche (PINK:RHHBY) and Glooko partnered to provide wireless data transmission between iPhones and glucose meters for patients with diabetes.
Mobile diabetes management startup Glooko lent its MeterSync infrared data transfer technology to enable diabetic patients to access readings from Roche’s Accu-Chek blood glucose meters.
Docs resist prostate test recommendation | MassDevice.com On Call
MASSDEVICE ON CALL — Primary care docs surveyed by Johns Hopkins University researchers say they’re unlikely to curtail their use of a test to detect prostate cancer, despite recommendations from the U.S. Preventive Services Task Force.
The USPSTF stirred up a controversy last year when it suggested that routine prostate-specific antigen tests for healthy men might do more harm than good.